INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
JJ
Jenkins JerrySVP, CHRO
GETYGetty Images Holdings, Inc.
Open-market sale
SELL$588
2,558 sh
Sep 9, 2026Sep 11, 2026
Page 129 of 532
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUY
traded Sep 9, 2026
+2d
SEC Form 4

Evidence

21
CM
Craddock John Mitchell Jr.Chief Operating Officer
SBSISOUTHSIDE BANCSHARES INC
Open-market sale
SELL$13K
415 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

21
RM
Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$260K
800 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$303K
1,431 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$584K
2,800 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$303K
1,440 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$418K
2,000 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,920 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$914K
4,400 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$285K
1,360 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

18
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$652K
7,171 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

17
KS
Kerr Michael SGeneral Counsel
QTWOQ2 Holdings, Inc.
Open-market sale
SELL$39K
636 sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

16
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$898K
13.8K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
1,169 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
920 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
360 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$93K
440 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

16
BT
Briggs TeresaDirector
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$35K
548 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
1,160 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

15
TP
Tak Paul PeterDirector, Chief Executive Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$621K
59.4K sh
Sep 11, 2026Sep 11, 2026
traded Sep 11, 2026
+0dSEC Form 4

Evidence

15
MS
Musunuri ShankarDirector, Chief Executive Officer
OCGNOcugen, Inc.
Open-market sale · 10b5-1 plan
SELL$525K
468.7K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

14
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$179K
10.2K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
80 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
120 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

13
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
1,206 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,630 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
1,100 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$1.97M
20.5K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC Form 4

Evidence

8
MS
Musunuri ShankarDirector, Chief Executive Officer
OCGNOcugen, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
57.3K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$558K
1,040 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$273K
512 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$277K
522 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$280K
520 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$273K
505 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$344K
640 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

7
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$345K
644 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

5
GC
Gracey CraigChief Accounting Officer
OMDAOmada Health, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
644 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

4
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$184K
347 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC Form 4

Evidence

UPBDUPBOUND GROUP, INC.Nov 2 – Nov 3
7 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  • SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K